{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:27Z","timestamp":1786119567090,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11,13]]},"DOI":"10.1097\/qad.0b013e32833eacfd","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T11:12:43Z","timestamp":1282907563000},"page":"2639-2644","source":"Crossref","is-referenced-by-count":5,"title":["Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV\/hepatitis C virus-coinfected individuals"],"prefix":"10.1097","volume":"24","author":[{"given":"Stacey A","family":"Rizza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan W","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina B","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D","family":"Badley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210130","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/QAD.0b013e3281084e4d","article-title":"Care of patients co-infected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel","volume":"21","author":"Soriano","year":"2007","journal-title":"AIDS"},{"key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood.V84.4.1020.1020","article-title":"Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study","volume":"84","author":"Eyster","year":"1994","journal-title":"Blood"},{"key":"R3-5-20210130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/321909","article-title":"Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis","volume":"33","author":"Graham","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"R5-5-20210130","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00002030-200305020-00011","article-title":"Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients","volume":"17","author":"Perez-Olmeda","year":"2003","journal-title":"AIDS"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa040842","article-title":"Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients","volume":"351","author":"Torriani","year":"2004","journal-title":"N Engl J Med"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1053\/j.gastro.2010.01.051","article-title":"Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.","volume":"138","author":"Stegmann","year":"2010","journal-title":"Gastroenterology"},{"key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"15903","DOI":"10.1073\/pnas.0906798106","article-title":"Suppression of a pro-apoptotic K+ channel as a mechanism for hepatitis C virus persistence","volume":"106","author":"Mankouri","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/medicina44070066","article-title":"Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study","volume":"44","author":"Guobuzaite","year":"2008","journal-title":"Medicina (Kaunas)"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2893.2009.01172.x","article-title":"Clearance of hepatitis C in chimpanzees is associated with intrahepatic T-cell perforin expression during the late acute phase.","volume":"17","author":"Watanabe","year":"2010","journal-title":"J Viral Hepat"},{"key":"R11-5-20210130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1479-5876-6-44","article-title":"The prediction of interferon treatment effects based on time series microarray gene expression profiles","volume":"6","author":"Huang","year":"2008","journal-title":"J Transl Med"},{"key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2893.2006.00832.x","article-title":"Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4","volume":"14","author":"Zekri","year":"2007","journal-title":"J Viral Hepat"},{"key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2008.05.011","article-title":"DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial","volume":"49","author":"Morgan","year":"2008","journal-title":"J Hepatol"},{"key":"R14-5-20210130","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"R16-5-20210130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2174\/156652409788167078","article-title":"The TRAIL to viral pathogenesis: the good, the bad and the ugly","volume":"9","author":"Cummins","year":"2009","journal-title":"Curr Mol Med"},{"key":"R17-5-20210130","first-page":"335","article-title":"Molecular determinants of response to TRAIL in killing of normal and cancer cells","volume":"6","author":"Kim","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/CBM-2007-3203","article-title":"Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women","volume":"3","author":"Martinez-Ferrandis","year":"2007","journal-title":"Cancer Biomark"},{"key":"R19-5-20210130","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1158\/1055-9965.EPI-06-0053","article-title":"Death receptor 4 variants and colorectal cancer risk","volume":"15","author":"Frank","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R20-5-20210130","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jneuroim.2005.06.021","article-title":"TNF-related apoptosis inducing ligand (TRAIL) gene polymorphism in Japanese patients with multiple sclerosis","volume":"167","author":"Kikuchi","year":"2005","journal-title":"J Neuroimmunol"},{"key":"R21-5-20210130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneuroim.2003.12.014","article-title":"Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis","volume":"149","author":"Weber","year":"2004","journal-title":"J Neuroimmunol"},{"key":"R22-5-20210130","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1086\/500954","article-title":"Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages","volume":"193","author":"Zhou","year":"2006","journal-title":"J Infect Dis"},{"key":"R23-5-20210130","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood-2005-03-1243","article-title":"CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL\/DR5-mediated apoptosis","volume":"106","author":"Herbeuval","year":"2005","journal-title":"Blood"},{"key":"R24-5-20210130","doi-asserted-by":"crossref","first-page":"11128","DOI":"10.1128\/JVI.75.22.11128-11136.2001","article-title":"Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL\/Apo2l","volume":"75","author":"Lum","year":"2001","journal-title":"J Virol"},{"key":"R25-5-20210130","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/507313","article-title":"Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: an AIDS Clinical Trials Group study","volume":"194","author":"Haas","year":"2006","journal-title":"J Infect Dis"},{"key":"R26-5-20210130","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1136\/gut.2004.056929","article-title":"Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake","volume":"54","author":"Mundt","year":"2005","journal-title":"Gut"},{"key":"R27-5-20210130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.cdd.4400823","article-title":"Host defense, viruses and apoptosis","volume":"8","author":"Barber","year":"2001","journal-title":"Cell Death Differ"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201011130-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:35:58Z","timestamp":1786041358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201011130-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,13]]},"references-count":26,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32833eacfd","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,13]]}}}